Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie in First-line Treatment in Participants With Unresectable Metastatic Colorectal Cancer

NCT06808685 is registered in ClinicalTrials.gov with Libbs Farmacêutica LTDA as lead sponsor.

NCT NCT06808685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06808685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie in First-line Treatment in Participants With Unresectable Metastatic Colorectal Cancer
Lead sponsor
Libbs Farmacêutica LTDA
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
November 30, 2027
Enrollment
133 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer